| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14712598.2014.907787 |
| P8608 | Fatcat ID | release_of4snffi65fifp74n5e4bbjyza |
| P698 | PubMed publication ID | 24707835 |
| P2093 | author name string | Yu Han | |
| Daiming Fan | |||
| Hongwei Zhang | |||
| Kaichun Wu | |||
| Qingchuan Zhao | |||
| Jianjun Yang | |||
| Liu Hong | |||
| P2860 | cites work | MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) | Q24630209 |
| Genome-wide epigenetic regulation of miRNAs in cancer | Q26863460 | ||
| miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells | Q28278471 | ||
| Noninvasive visualization of microRNA-16 in the chemoresistance of gastric cancer using a dual reporter gene imaging system | Q28486245 | ||
| Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres | Q33370714 | ||
| Genome-wide analysis of microRNA and mRNA expression signatures in hydroxycamptothecin-resistant gastric cancer cells | Q33565717 | ||
| miRNA signature associated with outcome of gastric cancer patients following chemotherapy | Q34082270 | ||
| A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance | Q34110688 | ||
| MicroRNAs and their therapeutic potential for human diseases: microRNAs, miR-143 and -145, function as anti-oncomirs and the application of chemically modified miR-143 as an anti-cancer drug | Q34144188 | ||
| miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. | Q34160439 | ||
| MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells | Q34228500 | ||
| Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by micro-RNA 330 and promoter methylation in cancer cells. | Q34237421 | ||
| Barrett esophagus and risk of esophageal cancer: a clinical review | Q34940151 | ||
| MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. | Q35008686 | ||
| Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells | Q35061283 | ||
| MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. | Q35747354 | ||
| Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer | Q35998435 | ||
| Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer | Q36406800 | ||
| MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients | Q36480448 | ||
| Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance | Q36815271 | ||
| Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma | Q36889793 | ||
| microRNA-mediated regulation of the tumor microenvironment | Q37452957 | ||
| The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas | Q37803216 | ||
| Angiogenesis-related molecular targets in esophageal cancer | Q37858534 | ||
| Epigenetic mechanisms in gastric cancer | Q38018086 | ||
| Drug resistance-related microRNAs in esophageal cancer | Q38029108 | ||
| Angiogenesis-related microRNAs in colon cancer | Q38060849 | ||
| Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway | Q38078784 | ||
| Modeling microRNA-transcription factor networks in cancer | Q38078853 | ||
| Molecular aspects of cancer cell resistance to chemotherapy | Q38084082 | ||
| miRNA profiling of cancer | Q38087057 | ||
| Emerging roles of microRNAs in the Wnt signaling network | Q38101361 | ||
| DNA damage repair and tolerance: a role in chemotherapeutic drug resistance | Q38101577 | ||
| The long and short of microRNA. | Q38102186 | ||
| Friend or foe: the role of microRNA in chemotherapy resistance | Q38102553 | ||
| Control of metastatic progression by microRNA regulatory networks | Q38111225 | ||
| Function of miRNA in controlling drug resistance of human cancers | Q38119992 | ||
| MicroRNA-21: a therapeutic target for reversing drug resistance in cancer | Q38122420 | ||
| Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway | Q38477901 | ||
| miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells | Q39083981 | ||
| MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3. | Q39112720 | ||
| MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. | Q39163245 | ||
| miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. | Q39184500 | ||
| Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel | Q39191770 | ||
| MiR-125a/b regulates the activation of cancer stem cells in paclitaxel-resistant colon cancer | Q39209084 | ||
| Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma | Q39305337 | ||
| MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma. | Q39329822 | ||
| MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17. | Q39335270 | ||
| miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells | Q39436512 | ||
| MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. | Q39467884 | ||
| Underexpression of miR-224 in methotrexate resistant human colon cancer cells. | Q39485396 | ||
| MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma | Q39598696 | ||
| Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. | Q39605990 | ||
| miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines | Q39606784 | ||
| Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells | Q39633529 | ||
| miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. | Q39677748 | ||
| miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines | Q39738386 | ||
| Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma | Q39767088 | ||
| Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells | Q42009448 | ||
| Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer | Q46422776 | ||
| MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy | Q47199545 | ||
| The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. | Q53298961 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 1103-1111 | |
| P577 | publication date | 2014-04-07 | |
| P1433 | published in | Expert Opinion on Biological Therapy | Q5421201 |
| P1476 | title | MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance | |
| P478 | volume | 14 |
| Q41589141 | Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding |
| Q35594181 | Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer |
| Q40864983 | MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer |
| Q49461513 | Prognostic significance of cystatin SN associated nomograms in patients with colorectal cancer. |
| Q38633179 | Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection |
| Q58617961 | miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer |
| Q37641780 | miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1. |
Search more.